Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Emory University
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Taofeek K. Owonikoko, Emory University Identifier:
First received: October 25, 2011
Last updated: August 27, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)